Cell Expansion Market by Product (Consumables, Instruments), Cell Type (Animal Cells, Human Cells), Application, End-User - Global Forecast 2024-2030
The Cell Expansion Market size was estimated at USD 19.36 billion in 2023 and expected to reach USD 20.90 billion in 2024, at a CAGR 8.23% to reach USD 33.70 billion by 2030.
Cell expansion refers to cultivating a large number of cells from a small initial population. This procedure is fundamental to various fields within biotechnology, including drug development, regenerative medicine, and clinical research. The process involves cultivating cells under controlled conditions to increase their number while maintaining their specific characteristics or functionality. Cell expansion is crucial in enabling researchers and clinicians to have sufficient quantities of cells for therapeutic applications, research studies, or further biological manufacturing processes. The innovations in cell culture technologies, bioreactors, and automation have improved the scalability and efficiency of cell expansion processes. The growing incidence of diabetes, cancer, and cardiovascular diseases globally drives demand for regenerative therapies and biopharmaceuticals, fueling the growth of the cell expansion market. However, the expenses associated with cell expansion instruments and consumables challenges the market growth. The increasing focus on personalized medicine and patient-specific treatments offers opportunities for the growth of the cell expansion market.
Regional InsightsThe United States dominates the cell expansion market in the Americas due to its robust biotechnology and pharmaceutical sectors, significant investments in research and development (R&D), and strong presence of leading industry players. The region witnesses a high adoption rate of advanced technologies, including automated cell expansion systems and bioreactors, catering to research and therapeutic applications. The promising growth of the cell expansion market in Canada and Brazil can be attributed to increased government funding for healthcare research, the rising prevalence of chronic diseases requiring cell therapy treatments, and regulatory support for stem cell research and therapy development. The Asia-Pacific region is emerging as a dynamic area in the cell expansion market, driven by economic growth, growing healthcare expenditure, and an increasing focus on biotechnology research. Countries like China, Japan, South Korea, and Australia are at the forefront, investing significantly in stem cell research and regenerative medicine. China's significant growth in cell expansion is propelled by governmental efforts to enhance biotechnology research. Japan's robust pharmaceutical sector and favorable regulatory environment for regenerative medicine majorly advance the region's market development in this field. The EMEA region showcases a diverse landscape for the cell expansion market, with Europe showcasing significant technological advancement, R&D activities, and adoption of cell-based therapies. Germany, the United Kingdom, and France are vital contributors, supported by favorable government policies, extensive research infrastructure, and collaborations between academia and industry. The cell expansion market in the African region is growing, driven by increasing research activities in biotechnology, rising investments in healthcare infrastructure, and the growing prevalence of chronic diseases requiring advanced therapeutic approaches.
Market InsightsMarket DynamicsThe market dynamics represent an ever-changing landscape of the Cell Expansion Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market DriversTechnological advancements in cell culture technologies
Rising incidence of cancer, diabetes, and cardiovascular diseases worldwide
Ongoing investments in R&D in stem cell research and regenerative medicine
Market RestraintsHigh cost of cell expansion instruments and consumables
Market OpportunitiesIntegration of microfluidic devices for cell expansion
Advancements in bioprinting technologies to revolutionize tissue engineering and regenerative medicine
Market ChallengesComplex regulatory landscape for approval of cell-based therapies
Market Segmentation AnalysisProduct: Expanding use of consumables in cell expansion due to their essential, repetitive use in research and biopharmaceutical production
Application: ell expansion in regenerative medicine & stem cell research for regenerative treatments globally
Market Disruption AnalysisPorter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning MatrixThe FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cell Expansion Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share AnalysisThe market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cell Expansion Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent DevelopmentsA Strategic Collaboration Between Thermo Fisher Scientific and Multiply Labs, Revolutionizing Cell Therapy Manufacturing through Automation
Thermo Fisher Scientific has entered into a pivotal collaboration with Multiply Labs to significantly enhance the automation of cell therapy manufacturing instruments, including the Thermo Scientific Heracell VIOS Automated Access CO2 Incubator and the Gibco Cell Therapy Systems (CTS) Rotea Counterflow Centrifugation System. This integration will allow for a substantial increase in efficiency, with the Heracell VIOS Incubator capable of hosting up to 18 G-Rex100M bioreactors simultaneously — a vast improvement over manual operations.
luri Launches PluriCDMO for Advanced Cell Therapy Manufacturing Services
Pluri, an innovative biotechnology firm has strategically expanded its operations with the establishment of PluriCDMO, a new division dedicated to providing comprehensive contract development and manufacturing organization (CDMO) services for cell therapies. PluriCDMO aims to support projects from early preclinical stages to late clinical trials and commercialization, leveraging over two decades of expertise in areas such as process and analytical development, process scale-up, and regulatory compliance, among others. This launch aligns with Pluri's commitment to driving forward the cell therapy sector by providing scalable, efficient, and GMP-compliant solutions, supported by comprehensive regulatory experience across major global markets.
Akadeum Life Sciences Advances Cell Therapy Research with Innovative Cell Isolation and Expansion Kits
Akadeum Life Sciences launched a groundbreaking series of products, designed for cell therapy research and development to mark a significant milestone in the field by facilitating the direct isolation of human immune cells from leukopaks and the activation/expansion of T cells. Embedded in this innovation is Akadeum's proprietary Buoyancy-Activated Cell Sorting (BACS) Microbubble technology, which promises a swift, one-hour process to yield high-quality, purified peripheral blood mononuclear cells (PBMCs) and T cells without the conventional need for lysis or density gradient centrifugation, safeguarding the integrity of fragile immune cells.
Strategy Analysis & RecommendationThe strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cell Expansion Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company ProfilesThe report delves into recent significant developments in the Cell Expansion Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Bio-Techne Corporation, Celltainer Biotech B.V., Corning Incorporated, Cytiva, Danaher Corporation, Eppendorf SE, G&G Technologies, Inc., GE Healthcare, iXCells Biotechnologies, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Neuromics, NexImmune, Novartis AG, PromoCell GmbH, REPROCELL Inc., Sartorius AG, Scinus Cell Expansion, Stemcell Technologies, Inc., Takara Bio Inc., Terumo BCT, TERUMO BCT, INC., and Thermo Fisher Scientific, Inc..
Market Segmentation & CoverageThis research report categorizes the Cell Expansion Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Consumables
Disposables
Media
Reagents
Sera
Instruments
Automated Cell Expansion System
Bioreactors
Microcarrier Bioreactors
Perfusion or Hollow Fiber Bioreactors
Cell Expansion Supporting Equipment
Cell Counters & Hemocytometers
Centrifuges
Flow Cytometers
Cell Type
Animal Cells
Human Cells
Differentiated Cells
Stem Cells
Adult Stem Cells
Embryonic Stem Cells
Induced Pluripotent Stem Cells
Application
Cancer & Cell-Based Research
Regenerative Medicine & Stem Cell Research
Vaccine Production
End-User
Biotechnology & Biopharmaceutical Companies
Cell Banks
Research Institutes
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year